Oscar Health, Inc. (OSCR) stock
OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3026% above fair value
$29.84−1.49 (-4.76%)
Close on Nov 17, 2026Market cap $9.21BP/E 21.3Yield –
Oscar Health total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Oscar Health's total debt was $431.63M at Jun 30, 2026. For fiscal 2025 it was $430.10M, up 43.6% from the year before. The highest annual figure on record is $430.10M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $430.10M | +43.6% |
| FY2024 | Dec 31, 2024 | $299.56M | +0.3% |
| FY2023 | Dec 31, 2023 | $298.78M | +0.3% |
| FY2022 | Dec 31, 2022 | $298.00M | – |
| FY2021 | Dec 31, 2021 | $0 | -100.0% |
| FY2020 | Dec 31, 2020 | $142.49M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $431.63M | +43.9% |
| Q1 FY2026 | Mar 31, 2026 | $430.88M | +43.7% |
| Q4 FY2025 | Dec 31, 2025 | $430.10M | +43.6% |
| Q3 FY2025 | Sep 30, 2025 | $686.29M | +129.3% |
| Q2 FY2025 | Jun 30, 2025 | $299.94M | +0.3% |
| Q1 FY2025 | Mar 31, 2025 | $299.75M | +0.3% |
| Q4 FY2024 | Dec 31, 2024 | $299.56M | +0.3% |
| Q3 FY2024 | Sep 30, 2024 | $299.36M | +0.3% |
| Q2 FY2024 | Jun 30, 2024 | $299.17M | +0.3% |
| Q1 FY2024 | Mar 31, 2024 | $298.97M | +0.3% |
| Q4 FY2023 | Dec 31, 2023 | $298.78M | +0.3% |
| Q3 FY2023 | Sep 30, 2023 | $298.58M | +0.3% |
| Q2 FY2023 | Jun 30, 2023 | $298.39M | +0.3% |
| Q1 FY2023 | Mar 31, 2023 | $298.19M | +0.3% |
| Q4 FY2022 | Dec 31, 2022 | $298.00M | – |
| Q3 FY2022 | Sep 30, 2022 | $297.81M | – |
| Q2 FY2022 | Jun 30, 2022 | $297.61M | – |
| Q1 FY2022 | Mar 31, 2022 | $297.42M | – |
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q3 FY2021 | Sep 30, 2021 | $0 | – |
| Q2 FY2021 | Jun 30, 2021 | $0 | – |
| Q1 FY2021 | Mar 31, 2021 | $0 | – |
| Q4 FY2020 | Dec 31, 2020 | $142.49M | – |
See a number that looks wrong?